Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 25;55(1):18-25.
doi: 10.1055/s-0041-1740085. eCollection 2022 Feb.

Primary Prevention of Cancer-Related Lymphedema Using Preventive Lymphatic Surgery: Systematic Review and Meta-analysis

Affiliations

Primary Prevention of Cancer-Related Lymphedema Using Preventive Lymphatic Surgery: Systematic Review and Meta-analysis

Pedro Ciudad et al. Indian J Plast Surg. .

Abstract

Background Several studies have proven prophylactic lymphovenous anastomosis (LVA) performed after lymphadenectomy can potentially reduce the risk of cancer-related lymphedema (CRL) without compromising the oncological treatment. We present a systematic review of the current evidence on the primary prevention of CRL using preventive lymphatic surgery (PLS). Patients and Methods A comprehensive search across PubMed, Cochrane-EBMR, Web of Science, Ovid Medline (R) and in-process, SCOPUS, and ScienceDirect was performed through December 2020. A meta-analysis with a random-effect method was accomplished. Results Twenty-four studies including 1547 patients fulfilled the inclusion criteria. Overall, 830 prophylactic LVA procedures were performed after oncological treatment, of which 61 developed lymphedema. The pooled cumulative rate of upper extremity lymphedema after axillary lymph node dissection (ALND) and PLS was 5.15% (95% CI, 2.9%-7.5%; p < 0.01). The pooled cumulative rate of lower extremity lymphedema after oncological surgical treatment and PLS was 6.66% (95% CI < 1-13.4%, p-value = 0.5). Pooled analysis showed that PLS reduced the incidence of upper and lower limb lymphedema after lymph node dissection by 18.7 per 100 patients treated (risk difference [RD] - 18.7%, 95% CI - 29.5% to - 7.9%; p < 0.001) and by 30.3 per 100 patients treated (RD - 30.3%, 95% CI - 46.5% to - 14%; p < 0.001), respectively, versus no prophylactic lymphatic reconstruction. Conclusions Low-quality studies and a high risk of bias halt the formulating of strong recommendations in favor of PLS, despite preliminary reports theoretically indicating that the inclusion of PLS may significantly decrease the incidence of CRL.

Keywords: “lymph node excision” (mesh); “lymphatic vessels” (mesh); “lymphedema” (mesh); “microsurgery” (mesh); “primary prevention” (mesh).

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None declared.

Figures

Fig. 1
Fig. 1
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram.
Fig. 2
Fig. 2
Risk of bias analysis of included studies. (Red [-]: high risk of bias; yellow (?): unclear risk of bias; green (+): low risk of bias).

References

    1. Ciudad P, Sabbagh M D, Agko M. Surgical management of lower extremity lymphedema: a comprehensive review. Indian J Plast Surg. 2019;52(01):81–92. - PMC - PubMed
    1. Ghanta S, Cuzzone D A, Torrisi J S. Regulation of inflammation and fibrosis by macrophages in lymphedema. Am J Physiol Heart Circ Physiol. 2015;308(09):H1065–H1077. - PMC - PubMed
    1. Kung T A, Champaneria M C, Maki J H, Neligan P C. Current concepts in the surgical management of lymphedema. Plast Reconstr Surg. 2017;139(04):1003e–1013e. - PubMed
    1. Benoit L, Boichot C, Cheynel N. Preventing lymphedema and morbidity with an omentum flap after ilioinguinal lymph node dissection. Ann Surg Oncol. 2005;12(10):793–799. - PubMed
    1. Boccardo F, Valenzano M, Costantini S. LYMPHA technique to prevent secondary lower limb lymphedema. Ann Surg Oncol. 2016;23(11):3558–3563. - PubMed